Your browser doesn't support javascript.
loading
Riluzole and spinocerebellar ataxia type 2: the ATRIL trial.
Velázquez-Pérez, Luis; Rodríguez-Labrada, Roberto.
Affiliation
  • Velázquez-Pérez L; Cuban Academy of Sciences, Havana, Cuba. Electronic address: luisvelazquez@ceniai.inf.cu.
  • Rodríguez-Labrada R; Cuban Neuroscience Centre, Havana, Cuba.
Lancet Neurol ; 21(3): 204-205, 2022 03.
Article in En | MEDLINE | ID: mdl-35063118
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Riluzole / Spinocerebellar Ataxias Limits: Humans Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2022 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Riluzole / Spinocerebellar Ataxias Limits: Humans Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2022 Document type: Article Country of publication: United kingdom